Controlled Substances News & Updates


2022 April- DEA Requiring Online Submission Applications and Renewals

2022 April- Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I

2022 April- Placement of Five Synthetic Cannabinoids in Schedule I

2022 July- Notice of federal rulemaking for controlled substances on vessels, aircraft, and certain other entities

2022 July 27th- Withdrawal of proposed rule for placement as Schedule I the following: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT)

2022 July 19th-Federal Registry Notice- Schedules of Controlled Substances: Removal of Fenfluramine From Control

Past Articles


Return to Controlled Substances Main Page